RGS14 Human

Regulator of G-Protein Signaling 14 Human Recombinant
Shipped with Ice Packs
In Stock

Description

G-Protein Signaling Regulation

RGS14 acts as a GAP for Gαi/o subunits, accelerating GTP hydrolysis and terminating GPCR signaling . This activity is critical for modulating downstream pathways, including cAMP and ERK signaling.

Synaptic Plasticity and Learning

  • Hippocampal CA2 Neurons: RGS14 suppresses long-term potentiation (LTP) and hippocampal-based learning by localizing to dendritic spines .

  • Nuclear Shuttling: Dynamically regulates nucleocytoplasmic distribution, with nuclear localization linked to distinct physiological functions .

Genetic Variants and Functional Impact

Human RGS14 variants disrupt nucleocytoplasmic shuttling and synaptic plasticity:

VariantLocationEffectPhysiological Outcome
L505RNESAbolishes Gαi1-GDP binding; disrupts XPO1 interaction .Nuclear accumulation; impaired LTP suppression .
R507QNESPartially reduces Gαi1-GDP binding; weakens XPO1 interaction .Altered nucleocytoplasmic equilibrium .

Key Findings:

  • L505R and R507Q: Found in human populations, these variants disrupt RGS14’s ability to inhibit LTP in hippocampal neurons .

  • Mouse Models: Mice expressing L505R exhibit normal spatial learning but altered synaptic plasticity, highlighting distinct nuclear vs. cytoplasmic roles .

Expression Patterns in Human Tissues

RGS14 exhibits tissue-specific and subcellular localization:

TissueExpressionLocalization
BrainEnriched in hippocampal CA2 pyramidal neurons and striatal nuclei .Dendritic spines (cytoplasmic), nuclei (rare) .
KidneyInteracts with NHERF1 in proximal tubules; regulates phosphate reabsorption .Cytoplasmic (via PDZ ligand interactions) .

Regional Brain Expression:

  • Hippocampus: Strong CA2 pyramidal neuron staining .

  • Amygdala/Striatum: Nuclear RGS14 observed in subsets of neurons .

Neuronal Signaling and Disease

  • Ras-ERK Pathway: RGS14 selectively binds H-Ras, forming complexes with Raf-MEK-ERK to sustain ERK activation .

  • Synaptic Plasticity: Overexpression in V2 visual cortex enhances object-recognition memory in mice .

Renal Physiology

  • Phosphate Reabsorption: Human RGS14 binds NHERF1 via its PDZ ligand, stabilizing NPT2A transporters in renal proximal tubules .

Disease Implications

  • Kidney Disorders: GWAS links RGS14 variants to phosphate metabolism and kidney diseases .

  • Neurological Disorders: Dysregulation may contribute to hippocampal-based learning deficits .

Product Specs

Introduction
RGS14, or Regulator of G-protein signaling 14, belongs to the regulator of G protein signaling family. This protein is characterized by its RGS domain, two Raf-like Ras-binding domains (RBDs), and a GoLoco motif. Functionally, RGS14 modulates G-protein signaling activity. It achieves this by employing its GoLoco domain to bind to specific activated, GTP-bound G alpha subunits. Acting as a scaffolding protein, RGS14 integrates G protein and H-Ras/ERK/MAP kinase signaling pathways. This strategic positioning allows it to control plasticity in CA2 neurons. Given its high concentration in CA2 pyramidal neurons, RGS14 plays a crucial role in regulating synaptic plasticity at these synapses and influencing hippocampal-based learning and memory.
Description
Recombinant Human RGS14, produced in E. coli, is a single, non-glycosylated polypeptide chain. It comprises 586 amino acids (specifically, amino acids 1-566) and exhibits a molecular weight of 63.6kDa. The protein is engineered with a 20 amino acid His-tag at its N-terminus and purified using specialized chromatographic techniques.
Physical Appearance
The product appears as a clear, colorless solution that has been sterilized by filtration.
Formulation
The RGS14 protein is provided in a solution at a concentration of 0.5mg/ml. The solution is buffered with 20mM Tris-HCl at a pH of 7.5 and contains 10% glycerol, 1mM DTT, and 200mM NaCl.
Stability
For short-term storage (up to 2-4 weeks), the product can be stored at 4°C. For extended storage, it is recommended to store the product frozen at -20°C. To ensure optimal long-term stability, consider adding a carrier protein such as HSA or BSA (at a concentration of 0.1%). It's important to avoid repeated freeze-thaw cycles to maintain product integrity.
Purity
The purity of the RGS14 protein is determined to be greater than 80% based on SDS-PAGE analysis.
Synonyms
Regulator of G-protein signaling 14, RGS14.
Source
Escherichia Coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MPGKPKHLGV PNGRMVLAVS DGELSSTTGP QGQGEGRGSS LSIHSLPSGP SSPFPTEEQP VASWALSFER LLQDPLGLAY FTEFLKKEFS AENVTFWKAC ERFQQIPASD TQQLAQEARN IYQEFLSSQA LSPVNIDRQA WLGEEVLAEP RPDMFRAQQL QIFNLMKFDS YARFVKSPLY RECLLAEAEG RPLREPGSSR LGSPDATRKK PKLKPGKSLP LGVEELGQLP PVEGPGGRPL RKSFRRELGG TANAALRRES QGSLNSSASL DLGFLAFVSS KSESHRKSLG STEGESESRP GKYCCVYLPD GTASLALARP GLTIRDMLAG ICEKRGLSLP
DIKVYLVGNE QALVLDQDCT VLADQEVRLE NRITFELELT ALERVVRISA KPTKRLQEAL QPILEKHGLS PLEVVLHRPG EKQPLDLGKL VSSVAAQRLV LDTLPGVKIS KARDKSPCRS QGCPPRTQDK ATHPPPASPS SLVKVPSSAT GKRQTCDIEG LVELLNRVQS SGAHDQRGLL
RKEDLVLPEF LQLPAQGPSS EETPPQTKSA AQPIGGSLNS TTDSAL.

Q&A

What is the basic structure and function of RGS14 in human neural systems?

RGS14 is a complex multidomain signaling protein that acts as a natural suppressor of synaptic plasticity, particularly in hippocampal CA2 neurons. Structurally, RGS14 contains several distinctive functional domains:

  • An RGS domain that serves as a GTPase-activating protein (GAP) for Gαi/o subunits

  • Tandem Ras Binding Domains (RBDs) that interact with small GTPases

  • A G protein Regulatory (GPR) motif that binds to inactive Gαi1-GDP and Gαi3-GDP

This multidomain architecture enables RGS14 to function at the intersection of multiple signaling pathways, including G protein signaling, Ras/MAP kinases, and calcium pathways that underlie synaptic plasticity and learning processes .

How can researchers differentiate between the functions of RGS14's individual domains?

To isolate and study individual domain functions, researchers should employ domain-specific mutation strategies:

  • Create truncated constructs containing only specific domains (e.g., RBD1, RBD2, or RGS domains)

  • Introduce point mutations that selectively disrupt binding to specific partners

  • Use GST pull-down assays to compare binding profiles of different domain constructs

Research has demonstrated that the first RBD mediates interaction with H-Ras, while the contribution of the second RBD appears minimal. Pull-down experiments showed that GST-RGS14.RBD1 effectively bound activated H-Ras, whereas GST-RGS14.RBD2 did not . For comprehensive domain analysis, isothermal titration calorimetry (ITC) provides direct measurement of binding affinities, as demonstrated in studies showing that RGS14(RBD1.RBD2) binds activated H-Ras with significantly higher affinity (KD ~10 μM) than inactive H-Ras (KD >200 μM) .

What are the optimal methods for detecting endogenous RGS14 in human neural tissues?

For reliable detection of endogenous RGS14 in human neural tissues, researchers should consider a multi-technique approach:

RNA-level detection:

  • RT-PCR with specific primers targeting different regions of RGS14 mRNA

  • Use primers designed to span exon junctions to avoid genomic DNA amplification

  • Include multiple primer pairs (as done in RGS14-KO validation studies with primers targeting different regions)

Protein-level detection:

  • Western blotting with validated antibodies

  • Immunohistochemistry/immunofluorescence for spatial distribution

  • Subcellular fractionation to determine compartmentalization

When verifying knockdown efficiency, both RNA and protein detection should be employed. Studies have shown that siRNA pools targeting rat RGS14 efficiently reduced expression at both protein and mRNA levels, with validation using multiple individual oligonucleotide duplexes to confirm specificity .

How does RGS14 shuttle between nuclear and cytoplasmic compartments, and what techniques best capture this dynamic process?

RGS14 is a nucleocytoplasmic shuttling protein, suggesting that balanced nuclear import/export is essential for its functions . To effectively study this shuttling behavior:

  • Use live cell imaging with fluorescently-tagged RGS14 constructs

  • Employ subcellular fractionation followed by western blotting

  • Implement pharmacological approaches with nuclear export inhibitors (e.g., Leptomycin B)

  • Create mutations in potential nuclear localization signals (NLS) and nuclear export signals (NES)

Recent studies of human genetic variants demonstrate that certain mutations (such as L505R and R507Q) may disrupt this shuttling process, potentially affecting RGS14's ability to suppress synaptic plasticity in dendritic spines . For detailed analysis of shuttling dynamics, Fluorescence Recovery After Photobleaching (FRAP) and photoactivatable fluorescent protein fusions can reveal real-time trafficking rates.

How does RGS14 specifically modulate the ERK/MAPK pathway in neurons?

RGS14 serves as a scaffolding protein that coordinates H-Ras signaling to the ERK/MAPK pathway through several mechanisms:

  • Direct binding to activated H-Ras through its first RBD (RBD1)

  • Facilitation of multiprotein complex assembly with B-Raf, MEK1, and ERK1

  • Regulation of the duration of ERK activation in response to neurotrophic factors

In PC12 cells, RGS14 has been shown to be crucial for both NGF- and bFGF-promoted neurite outgrowth. siRNA-mediated knockdown of RGS14 shortens the duration of ERK activation in response to these factors, resulting in impaired neuritogenesis . This indicates that RGS14 may function to sustain ERK signaling required for neuronal differentiation processes.

To study this modulatory function, researchers should:

  • Use co-immunoprecipitation to detect multiprotein complex formation

  • Employ phospho-specific antibodies to monitor ERK activation kinetics

  • Compare wild-type cells with RGS14 knockdown or knockout models

How can researchers resolve the contradictory findings regarding RGS14's selectivity for Ras versus Rap GTPases?

The literature contains contradictory findings regarding RGS14's preference for binding Ras versus Rap GTPases. To resolve these contradictions, researchers should:

  • Distinguish between in vitro and cellular contexts: While RGS14 binds promiscuously to both Ras and Rap isoforms in vitro, cellular co-immunoprecipitation experiments demonstrate preferential association with activated H-Ras over Rap proteins .

  • Use multiple interaction assays:

    • GST pull-down assays for initial screening

    • Co-immunoprecipitation from mammalian cells for physiological relevance

    • Isothermal titration calorimetry for direct binding kinetics

    • FRET-based assays for real-time interaction dynamics

  • Test full-length protein and isolated domains separately: The tandem RBD portion of RGS14 may behave differently than the full-length protein, as demonstrated by the discrepancy between yeast two-hybrid results and cellular experiments .

A comprehensive analysis by Willard et al. showed that although GST-RGS14 fusion proteins bound to multiple Ras and Rap isoforms in vitro, in cellular contexts full-length RGS14 preferentially co-immunoprecipitated with activated H-Ras, with minimal or no binding to Rap1A, Rap1B, Rap2A, or Rap2B .

What are the most appropriate knockout models for studying RGS14 function?

For effective RGS14 knockout studies, researchers should consider:

Generation of RGS14-KO mice:

  • Target critical exons encoding functional domains

  • Verify knockout through multiple methods:

    • Genomic PCR with primers spanning the deletion

    • RT-PCR with multiple primer sets targeting different regions

    • Western blotting to confirm protein absence

The established RGS14-KO model (RGS14tm1-lex) has proven valuable for studying RGS14's role in synaptic plasticity. These mice display markedly enhanced synaptic plasticity in CA2 neurons, suggesting RGS14's role as a natural suppressor of both synaptic plasticity and hippocampal-based learning .

Cellular models:

  • siRNA knockdown in neuronal cell lines (e.g., PC12 cells)

  • CRISPR-Cas9 genome editing in human neural cell lines

  • Primary neuronal cultures from RGS14-KO animals

For transient knockdown studies, validation with multiple siRNA duplexes is essential to confirm specificity, as demonstrated in studies showing that four different siRNA duplexes targeting RGS14 all impaired NGF-mediated neurite formation .

How can researchers effectively evaluate the impact of RGS14 on neuronal morphology and function?

To comprehensively assess RGS14's impact on neuronal morphology and function:

Morphological analysis:

  • Neurite outgrowth assays (as in PC12 cells) with quantification of:

    • Neurite length

    • Branching complexity

    • Growth cone dynamics

  • Dendritic spine morphology assessment in primary neurons

Functional assessment:

  • Electrophysiological recordings of synaptic plasticity (LTP/LTD)

  • Calcium imaging to measure intracellular calcium dynamics

  • Live-cell imaging of signaling pathway activation using FRET sensors

In PC12 cells, NGF-promoted neurite outgrowth serves as an excellent model system. RGS14 knockdown significantly reduces the average length of NGF-promoted neurites compared to control cells . Similarly, this approach can be applied to assess bFGF-promoted neuritogenesis and neurite formation stimulated by activated mutants of H-Ras (G12V) and B-Raf (V600E) .

What approaches should be used to characterize the functional impact of human RGS14 genetic variants?

To characterize human RGS14 variants such as L505R (LR) and R507Q (RQ):

Structural analysis:

  • In silico modeling to predict impact on protein folding and domain interactions

  • Circular dichroism to assess secondary structure alterations

  • Limited proteolysis to evaluate conformational changes

Functional assays:

  • Nucleocytoplasmic shuttling analysis using fluorescent fusion proteins

  • Binding assays with known partners (H-Ras, G proteins)

  • Electrophysiological assessment of effects on synaptic plasticity

Cellular localization:

  • Immunofluorescence to determine subcellular distribution

  • Biochemical fractionation to quantify distribution between cellular compartments

  • Live-cell imaging to track trafficking dynamics

Recent research has shown that human genetic variants can disrupt RGS14 nuclear shuttling, which may have significant implications for its function in dendritic spines of hippocampal neurons . This suggests that balanced nuclear import/export is essential for RGS14's ability to suppress synaptic plasticity.

How do researchers distinguish between pathogenic and non-pathogenic variants of RGS14?

To differentiate pathogenic from non-pathogenic RGS14 variants:

  • Conservation analysis:

    • Evaluate evolutionary conservation of affected residues across species

    • Assess conservation across RGS family members

  • Structure-function correlation:

    • Map variants to functional domains

    • Determine whether variants affect known binding interfaces

  • Functional assays:

    • Compare effects on canonical RGS14 functions (e.g., GAP activity, GTPase binding)

    • Assess impact on downstream signaling pathways (ERK activation)

    • Evaluate effects on neurite outgrowth or synaptic plasticity

  • Population frequency data:

    • Analyze prevalence in general population databases

    • Compare frequency in affected versus unaffected individuals

Variants that disrupt nuclear shuttling, such as L505R and R507Q, may represent functionally significant alterations, as proper subcellular localization appears critical for RGS14's role in synaptic plasticity regulation .

What are the most effective techniques for studying RGS14 protein-protein interactions in human neural contexts?

For comprehensive analysis of RGS14 protein-protein interactions:

In vitro approaches:

  • GST pull-down assays with recombinant proteins

  • Isothermal titration calorimetry (ITC) for direct binding kinetics and stoichiometry

  • Surface plasmon resonance for real-time binding analysis

Cellular approaches:

  • Co-immunoprecipitation under endogenous expression conditions

  • Proximity ligation assay (PLA) for detecting interactions in situ

  • FRET/BRET-based interaction assays for live-cell dynamics

Proteomic approaches:

  • BioID or APEX2 proximity labeling to identify the interactome

  • Quantitative mass spectrometry following immunoprecipitation

  • Crosslinking mass spectrometry to map interaction interfaces

Studies have demonstrated significant differences between in vitro and cellular interaction profiles. While GST pull-down assays showed promiscuous binding of RGS14 to multiple Ras and Rap isoforms, cellular co-immunoprecipitation revealed selective binding to activated H-Ras . This highlights the importance of validating interactions across multiple experimental systems.

How can researchers effectively measure the impact of RGS14 on synaptic plasticity in human neurons?

To assess RGS14's impact on synaptic plasticity in human neurons:

Electrophysiological approaches:

  • Patch-clamp recordings from human iPSC-derived neurons

  • Field potential recordings from organotypic cultures

  • Optogenetic stimulation paired with electrophysiology

Molecular readouts:

  • Phosphorylation of plasticity-associated proteins (CaMKII, AMPA receptors)

  • Trafficking of synaptic receptors using surface biotinylation

  • Local protein synthesis using puromycin labeling

Imaging approaches:

  • Spine morphology changes using super-resolution microscopy

  • Calcium dynamics using genetically-encoded calcium indicators

  • AMPA receptor trafficking using pH-sensitive fluorescent tags

When comparing wild-type and RGS14-manipulated conditions, researchers should quantify multiple parameters of synaptic plasticity, including induction threshold, magnitude, and maintenance phase characteristics. In RGS14-KO mice, markedly enhanced synaptic plasticity was observed in CA2 neurons, consistent with RGS14's role as a natural suppressor of plasticity .

What experimental paradigms best evaluate RGS14's potential as a therapeutic target for cognitive enhancement?

To evaluate RGS14 as a potential therapeutic target:

Behavioral paradigms:

  • Hippocampal-dependent learning tasks (e.g., Morris water maze, contextual fear conditioning)

  • Novel object recognition for declarative memory

  • Working memory tasks (e.g., T-maze, radial arm maze)

Target validation approaches:

  • Conditional and inducible knockout models to assess temporal specificity

  • Region-specific manipulation using viral vectors

  • Dose-response studies with small molecule modulators

Translational considerations:

  • Assessment in aged animal models

  • Evaluation in disease-relevant models (Alzheimer's, schizophrenia)

  • Examination of potential compensatory mechanisms

How can researchers design experiments to assess potential side effects of RGS14 modulation?

To comprehensively evaluate potential side effects of RGS14 modulation:

Physiological assessment:

  • Cardiovascular parameters (heart rate, blood pressure)

  • Metabolic measures (glucose tolerance, energy expenditure)

  • Neuroendocrine function (stress hormone levels)

Neurological evaluation:

  • Seizure susceptibility testing

  • Sensorimotor function assessment

  • Sleep architecture analysis

Behavioral profiling:

  • Anxiety and depression-like behaviors

  • Social interaction tests

  • Addiction potential assessment

Molecular monitoring:

  • Compensatory changes in related RGS proteins

  • Alterations in downstream signaling networks

  • Transcriptomic and proteomic profiling

Given RGS14's role as a natural suppressor of synaptic plasticity , its inhibition might lead to excessive plasticity with potential consequences for circuit stability. Additionally, RGS14's involvement in ERK signaling pathways suggests that its modulation could affect diverse cellular processes beyond cognition.

Product Science Overview

Introduction

Regulator of G-Protein Signaling 14 (RGS14) is a multifunctional protein that plays a crucial role in the regulation of G-protein signaling pathways. It is a member of the RGS protein family, which is known for its ability to accelerate the GTPase activity of Gα subunits, thereby terminating G-protein-coupled receptor (GPCR) signaling. RGS14 is encoded by the RGS14 gene in humans and has been extensively studied for its diverse functions and interactions.

Structure and Domains

RGS14 contains several distinct domains that contribute to its multifunctionality:

  • RGS Domain: This domain is responsible for its GTPase-activating protein (GAP) activity, which accelerates the hydrolysis of GTP to GDP on Gα subunits, leading to the inactivation of G-proteins .
  • Raf-like Ras-binding Domains (RBDs): RGS14 has two tandem Ras-binding domains that allow it to interact with members of the Ras and Rap families of small GTPases .
  • GoLoco Motif: This motif enables RGS14 to bind to specific Gα subunits in their GDP-bound state, further regulating G-protein signaling .
Functions and Mechanisms

RGS14 is involved in various cellular processes through its interactions with different signaling molecules:

  • G-Protein Regulation: By acting as a GAP, RGS14 accelerates the deactivation of Gα subunits, thereby modulating GPCR signaling pathways .
  • Ras/Rap Signaling: RGS14 can bind to both Ras and Rap GTPases, although it has been shown to selectively interact with activated H-Ras in cellular contexts . This interaction facilitates the formation of a multiprotein complex that promotes sustained ERK activation, which is essential for processes like neuronal differentiation .
  • Neuronal Functions: RGS14 has been implicated in the regulation of synaptic plasticity and memory. It is enriched in specific regions of the brain, such as the CA2 pyramidal neurons, where it suppresses synaptic plasticity and hippocampal-based learning .
Research and Implications

Research on RGS14 has revealed its potential implications in various physiological and pathological conditions:

  • Memory and Learning: Studies have shown that increasing the expression of RGS14 in certain brain regions can enhance the conversion of short-term to long-term memory .
  • Neuronal Differentiation: RGS14 plays a role in neuronal differentiation by facilitating the formation of signaling complexes that promote ERK activation .
  • Disease Associations: Dysregulation of RGS14 has been linked to various neurological disorders, highlighting its importance in maintaining normal brain function .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.